The status and value of thrombolysis drugs in the treatment of limb ischemia        HUANG Xiao-zhong, ZHANG Ji-wei. Department of Vascular Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai200127, China
Corresponding author: ZHANG Ji-wei, E-mail：zhangjiwei001@sina.com
Abstract    Artery thromboembolism of limbs accouts for a large proportion in peripheral vascular diseases with high morbidity and mortality. It could harm the preservation of limbs and human health. Fibrinolytic therapy is one of the most important ways of the treatment. In recent years thrombolysis drug use and research have made a lot of progress. Concentrated in two ways: (1) Deep and further understanding of the traditional thrombolysis drugs, achieveing the precise use. (2) New thrombolysis drugs success to fibrinolytic therapy bring new opportunities.